Purchase Order 36C26220P1512
Award Date 7/15/20
Potential Completion Date 9/30/20
Potential Value $167K
Federal Agency
Ultimate Awardee
Not listed NAICS Category
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
King of Prussia, PA 19406, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This federal contract award was issued by the Department of Veterans Affairs (VA) Veterans Health Administration to CSL Behring L.L.C., doing business as CSL Behring LLC, a global biotherapeutics company. The $154,935.10 firm fixed price delivery order was placed against CSL Behring's Pharmaceuticals and Drugs Federal Supply Schedule contract managed by the General Services Administration. The contract is for the supply of the Hereditary Angioedema treatment HAEGARDA and the intravenous...
- The Department of Veterans Affairs Veterans Health Administration, through its Veterans Integrated Service Network 22, awarded a $153,282.20 firm fixed-price delivery order to CSL Behring L.L.C. for the Hereditary Angioedema treatment HAEGARDA. This order was placed against CSL Behring's Pharmaceuticals and Drugs Federal Supply Schedule contract with the General Services Administration, which allows federal agencies to efficiently procure pharmaceuticals through task orders. The contract has...
- This is a firm fixed-price purchase order awarded by the U.S. Department of Veterans Affairs (VA) Veterans Integrated Service Network 21 (VISN 21) to CSL Behring L.L.C., a foreign-owned, for-profit pharmaceutical company, for an emergency drug purchase. The award, valued at $95,837.50, does not have a set-aside designation. CSL Behring holds several Indefinite Delivery Vehicles (IDVs) with the VA, including a Federal Supply Schedule contract for Pharmaceuticals and Drugs, a Blanket Purchase...
- This federal contract award was issued by the Department of Veterans Affairs (VA) Veterans Health Administration to CSL Behring L.L.C., doing business as CSL Behring LLC, a global biotherapeutics company. The $208,978.20 firm fixed price delivery order was issued against CSL Behring's Pharmaceuticals and Drugs Federal Supply Schedule contract with the VA and General Services Administration. The contract is to provide the Hereditary Angioedema treatment medication HAEGARDA to VA medical...
- This federal contract award was issued by the Department of Veterans Affairs Veterans Health Administration to CSL Behring L.L.C., a global biotherapeutics company, to provide the Hereditary Angioedema treatment HAEGARDA. The $174,148.50 firm fixed price delivery order was placed against CSL Behring's Pharmaceuticals and Drugs Federal Supply Schedule contract with the General Services Administration. The contract has no set-aside designation and the place of performance is CSL Behring's facility...
- CSL Behring LLC, a global biotherapeutics company specializing in plasma-derived and recombinant therapies, was awarded a delivery order valued at $124,239.92 by Veterans Integrated Service Network 8 (VISN 8) for emergency procurement of HAEGARDA C1 Inhibitor. The contract, awarded on October 22, 2025, with a completion date of November 22, 2025, utilizes firm fixed pricing and carries no set-aside designation. The award is issued under CSL Behring's existing Federal Supply Schedule contract for...
- This is a federal contract award to CSL Behring L.L.C., a global biotherapeutics company, for the delivery of the Hereditary Angioedema treatment HAEGARDA to the Department of Veterans Affairs (VA) and its regional Veterans Integrated Service Networks (VISNs). The $104,510.10 firm fixed price award was issued against CSL Behring's Pharmaceuticals and Drugs Federal Supply Schedule contract managed by the General Services Administration (GSA), allowing VA medical centers and other federal agencies...
- This is a federal contract award made by the Department of Veterans Affairs (VA) Veterans Health Administration to CSL Behring L.L.C., doing business as CSL Behring LLC, for the delivery of HAEGARDA, a pharmaceutical product used to treat Hereditary Angioedema. The $117,027.68 firm fixed price delivery order was issued against CSL Behring's Pharmaceuticals and Drugs Federal Supply Schedule contract with the General Services Administration (GSA). The contract has no set-aside designation and...
- This is a $101,660.40 delivery order awarded by the U.S. Department of Veterans Affairs (VA) to CSL Behring L.L.C., a foreign-owned, for-profit pharmaceutical company. The order was placed under CSL Behring's Federal Supply Schedule (FSS) contract for Pharmaceuticals and Drugs (FSS-61-IB), which has a ceiling value of $201,482,280 and is valid through September 2026. The delivery order is for emergency supplies and has a completion date of September 30, 2015. CSL Behring holds additional Blanket...
- This is a federal contract award to CSL Behring L.L.C., a global biotherapeutics company, by the Department of Veterans Affairs (VA) Veterans Health Administration for the supply of the Hereditary Angioedema treatment HAEGARDA. The contract, valued at $139,344.00, was issued as a Delivery Order against CSL Behring's Pharmaceuticals and Drugs Federal Supply Schedule contract with the General Services Administration (GSA). The contract has a firm fixed price pricing type and does not utilize any...